Patents by Inventor David Salomon

David Salomon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240093186
    Abstract: The disclosure provides, e.g., compositions, systems, and methods for targeting, editing, modifying, or manipulating a host cell's genome at one or more locations in a DNA sequence in a cell, tissue, or subject. Gene modifying systems for treating cystic fibrosis, e.g., in subjects having a mutation resulting in F508del, are described.
    Type: Application
    Filed: September 20, 2023
    Publication date: March 21, 2024
    Inventors: Robert Charles Altshuler, Anne Helen Bothmer, Daniel Raymond Chee, Cecilia Giovanna Silvia Cotta-Ramusino, Kyusik Kim, Randi Michelle Kotlar, Gregory David McAllister, Aamir Mir, Ananya Ray, Nathaniel Roquet, Carlos Sanchez, Barrett Ethan Steinberg, Robert James Citorik, William Edward Salomon, William Querbes, Luciano Henrique Apponi, Zhan Wang
  • Publication number: 20240084334
    Abstract: The disclosure provides, e.g., compositions, systems, and methods for targeting, editing, modifying, or manipulating a host cell's genome at one or more locations in a DNA sequence in a cell, tissue, or subject. Gene modifying systems for treating alpha-1 antitrypsin deficiency (AATD) are described.
    Type: Application
    Filed: September 18, 2023
    Publication date: March 14, 2024
    Inventors: Robert Charles Altshuler, Anne Helen Bothmer, Daniel Raymond Chee, Cecilia Giovanna Silvia Cotta-Ramusino, Kyusik Kim, Randi Michelle Kotlar, Gregory David McAllister, Ananya Ray, Nathaniel Roquet, Carlos Sanchez, Barrett Ethan Steinberg, William Edward Salomon, Robert James Citorik, William Querbes, Luciano Henrique Apponi, Zhan Wang
  • Publication number: 20240082429
    Abstract: The disclosure provides, e.g., compositions, systems, and methods for targeting, editing, modifying, or manipulating a host cell's genome at one or more locations in a DNA sequence in a cell, tissue, or subject. Gene modifying systems for treating phenylketonuria (PKU) are described.
    Type: Application
    Filed: October 26, 2023
    Publication date: March 14, 2024
    Inventors: Robert Charles Altshuler, Anne Helen Bothmer, Daniel Raymond Chee, Cecilia Giovanna Silvia Cotta-Ramusino, Kyusik Kim, Randi Michelle Kotlar, Gregory David McAllister, Ananya Ray, Nathaniel Roquet, Carlos Sanchez, Barrett Ethan Steinberg, William Edward Salomon, Robert James Citorik, William Querbes, Luciano Henrique Apponi, Zhan Wang
  • Publication number: 20160070031
    Abstract: The invention relates to a sol-gel method for producing an anti-reflective coating from alcoxide-type precursors, that can subsequently be applied to glass or plastic substrates by spraying. The invention also relates to optical and thermoelectrical devices that have been coated with said anti-reflective material. This coating increases the transmittance of the transparent substrates over which it is applied, as a result of which it is useful to apply over high concentration solar modules (HCPV), for both primary lenses and secondary lenses, in conventional silicon or in CSP tubes.
    Type: Application
    Filed: December 19, 2013
    Publication date: March 10, 2016
    Inventors: SebastiáN CAPARRÓS JIMÉNEZ, David SALOMÓN LEVY COHÉN, Marcos Daniel ZAYAT SOUSS, Erick CASTELLÓN ELIZONDO, David ALMENDRO FUENTES
  • Publication number: 20150125459
    Abstract: The present disclosure concerns the use of biologically active apelin peptides and compositions that are processed from larger precursor proteins and further post-translationally modified to influence cell growth. Particular methods are useful for promoting cell growth, while others are particularly useful for inhibiting cell growth.
    Type: Application
    Filed: January 9, 2015
    Publication date: May 7, 2015
    Applicant: The United States of America, as represented by the Secretary, Department of Health and Human Serv
    Inventors: Frank Cuttitta, Ingalill Avis, David Salomon
  • Patent number: 8946382
    Abstract: The present disclosure concerns the use of biologically active apelin peptides and compositions that are processed from larger precursor proteins and further post-translationally modified to influence cell growth. Particular methods are useful for promoting cell growth, while others are particularly useful for inhibiting cell growth.
    Type: Grant
    Filed: March 1, 2010
    Date of Patent: February 3, 2015
    Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Frank Cuttitta, Ingalill Avis, David Salomon
  • Publication number: 20140174186
    Abstract: The invention provides a system for leak detection of a fluid in a pipe network. The system includes flow meters, and vibration detectors adapted to be attached to a pipe at a location in the pipe network. A processor analyzes signals generated by the flow meters and vibration detectors to identify the presence of one or more leaks in the pipe network. The invention also provides a method for detecting and localizing leaks in a pipeline network, and a device comprising a flow meter integral with a vibration detector for use in the system of the invention.
    Type: Application
    Filed: February 25, 2014
    Publication date: June 26, 2014
    Applicant: Aquarius Spectrum Ltd.
    Inventor: David Salomon
  • Publication number: 20100221255
    Abstract: The present disclosure concerns the use of biologically active apelin peptides and compositions that are processed from larger precursor proteins and further post-translationally modified to influence cell growth. Particular methods are useful for promoting cell growth, while others are particularly useful for inhibiting cell growth.
    Type: Application
    Filed: March 1, 2010
    Publication date: September 2, 2010
    Inventors: Frank Cuttitta, Ingalill Avis, David Salomon
  • Publication number: 20080065529
    Abstract: In a method and system for securitizing contracts valued on an index, a special purpose entity (SPE) is provided and holds as substantially all of its assets a derivative contract with a contract dealer. The contract has an initial notional value and is tied to an index related to items traded by a multilateral transactional execution facility, such as futures contracts traded on an exchange. The held contract is also scalable so that the notional value can be increased on demand in exchange for a corresponding payment to the contract dealer and decreased on demand in exchange for a corresponding payment from the contract dealer. The SPE issues exchange tradable securities that derive value based on the value of the contract held by the SPE. To issue additional shares, assets are contributed to the contract dealer who increases the notional value of the contract held by the SPE. The increase in value of the contract supports the issuance of additional shares.
    Type: Application
    Filed: November 5, 2007
    Publication date: March 13, 2008
    Inventors: Christopher Bowen, Donald Carden, Zoltan Guttman, Richard Horowitz, David Salomon, Lanny Schwartz, David Yeres
  • Publication number: 20070136180
    Abstract: The present invention provides for an electronic exchange that provides a marketplace for the trading and settling of currency futures contracts, having methods and systems that include features such as an enhanced execution facility, clearing facility and futures contracts to facilitate such market without the disadvantages of the existing foreign exchange market centers and currency futures contract markets.
    Type: Application
    Filed: March 24, 2006
    Publication date: June 14, 2007
    Inventors: David Salomon, Vincent Viola, Larry Harris
  • Publication number: 20070122813
    Abstract: A method of detecting a neurodegenerative disease in a mammal, which method comprises assaying the copy number of a Cripto-1 gene or the expression level of a Cripto-1 gene product in the central nervous system of the mammal, wherein an amplification of the Cripto-1 gene or an overexpression of the Cripto-1 gene product is indicative of a neurodegenerative disease in the mammal; a method of inhibiting progression of a neurodegenerative disease in a mammal, which method comprises administering to the mammal an agent that inhibits Cripto-1 in an amount effective to inhibit Cripto-1 in the central nervous system of the mammal, whereupon the progression of the neurodegenerative disease is inhibited; and an isolated or purified oligonucleotide consisting essentially of the sequence of AAGCTATGGACTGCAGGAAGATGG (SEQ ID NO: 3) or AGAAGGCAGATGCCACTAGC (SEQ ID NO: 4).
    Type: Application
    Filed: October 1, 2004
    Publication date: May 31, 2007
    Inventors: David Salomon, Nancy Berman, Edward Stephens
  • Patent number: 7078176
    Abstract: The present invention provides methods and compositions for the detection and quantification of Cripto-1. In particular, the present invention provides methods and compositions for the detection and quantification of Cripto-1 in samples such as milk, plasma, serum, and other biological fluids. In particularly preferred embodiments, the present invention finds use in the detection and/or quantification of Cripto-1 in human milk, plasma, serum, and other biological fluids.
    Type: Grant
    Filed: January 23, 2002
    Date of Patent: July 18, 2006
    Assignee: The United States of America as represented by the Department of Health and Human Serivices
    Inventors: Caterina Bianco, David Salomon
  • Publication number: 20060127878
    Abstract: A polymeric hydrogel having a network of a macropores and micropores formed by copolymerizing at least one monomer having at least one double bond and at least one crosslinker having at least two double bonds in the presence of an organic additive forming a hydro-organic system with water, and uses thereof as separation media.
    Type: Application
    Filed: December 17, 2003
    Publication date: June 15, 2006
    Inventors: David Salomon, Greg Qiao, Alan Kwok
  • Publication number: 20050119962
    Abstract: In a method and system for securitizing contracts valued on an index, a special purpose entity (SPE) is provided and holds as substantially all of its assets a derivative contract with a contract dealer. The contract has an initial notional value and is tied to an index related to items traded by a multilateral transactional execution facility, such as futures contracts traded on an exchange. The held contract is also scalable so that the notional value can be increased on demand in exchange for a corresponding payment to the contract dealer and decreased on demand in exchange for a corresponding payment from the contract dealer. The SPE issues exchange tradable securities that derive value based on the value of the contract held by the SPE. To issue additional shares, assets are contributed to the contract dealer who increases the notional value of the contract held by the SPE. The increase in value of the contract supports the issuance of additional shares.
    Type: Application
    Filed: December 2, 2002
    Publication date: June 2, 2005
    Inventors: Christopher Bowen, Donald Carden, Zoltan Guttman, Richard Horowitz, David Salomon, Lanny Schwartz, David Yeres
  • Publication number: 20050038726
    Abstract: Methods for creating and providing securities for investors and other market-interested parties involve creating investment entities with associated assets and corresponding securities, such as shares in the investment entities, in a time effective manner and in response to an investor's demand. The assets of the investment entity may be formed as an exchange traded fund (“ETF”) and may include shares of stock, bonds, options, convertibles, currencies, warrants, futures, commodities, real estate, other hard or soft assets and/or other items of value. An investment entity may be formed in any suitable legal structure, such as, but not limited to, a corporation, organization, business trusts, partnerships or the like, that is capable of holding the assets of the investment entity. An investment entity may hold one or more portfolios of common stocks, bonds, or other assets.
    Type: Application
    Filed: August 4, 2004
    Publication date: February 17, 2005
    Inventors: David Salomon, Vincent Viola
  • Patent number: D699176
    Type: Grant
    Filed: June 2, 2011
    Date of Patent: February 11, 2014
    Assignee: Solaria Corporation
    Inventors: Asher David Salomon, Scott Paul Skinner